Fiscal period | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
Period End Date | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 |
Net patient service revenue | 1,911.19 | 1,733.95 | 1,779.76 | 1,723.11 | 3,253.39 | 3,183.16 | 2,780.00 | 2,438.91 | 2,154.01 | 1,816.61 |
Total Revenues | 1,911.19 | 1,733.95 | 1,779.76 | 1,723.11 | 3,253.39 | 3,183.16 | 2,780.00 | 2,438.91 | 2,154.01 | 1,816.61 |
Practice supplies and other operating expenses | 100.47 | 90.69 | 95.91 | 92.48 | 106.44 | 118.42 | 98.48 | 89.00 | 82.39 | 71.82 |
Practice salaries and benefits | 1,297.48 | 1,193.94 | 1,180.76 | 1,125.67 | 2,227.34 | 2,031.22 | 1,753.51 | 1,543.40 | 1,361.32 | 1,130.91 |
Depreciation and amortization | 32.15 | 28.44 | 25.93 | 24.36 | 78.86 | 89.26 | 64.23 | 45.99 | 39.97 | 30.82 |
General and administrative expenses | 263.36 | 248.95 | 244.51 | 232.22 | 385.86 | 372.57 | 305.92 | 247.53 | 218.21 | 193.54 |
Transformational and restructuring related expenses | 22.10 | 73.80 | 60.89 | 0.00 | -- | -- | -- | -- | -- | -- |
Gain on sale of building | 7.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | 1,708.27 | 1,635.82 | 1,608.00 | 1,474.72 | 2,798.50 | 2,611.47 | 2,222.13 | 1,925.91 | 1,701.88 | 1,427.09 |
Operating Income (Loss) | 202.92 | 98.13 | 171.76 | 248.39 | 454.89 | 571.69 | 557.87 | 513.00 | 452.13 | 389.52 |
Interest expense | 68.72 | 110.48 | 118.93 | 92.95 | 74.56 | 63.09 | 23.11 | 8.89 | 5.42 | 3.25 |
Equity in earnings of unconsolidated affiliate | 1.91 | 1.59 | 2.27 | 7.71 | 0.95 | 3.19 | 3.13 | 1.78 | -- | -- |
Investment income | 13.65 | 17.91 | 3.69 | 3.05 | 4.39 | 2.02 | 1.84 | 2.73 | 1.70 | 1.90 |
Loss on early extinguishment of debt | (14.53) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Income (loss) before income taxes | 135.23 | 7.15 | 58.78 | 166.21 | 385.67 | 513.80 | 539.73 | 508.62 | 448.41 | 388.17 |
Income tax (benefit) provision | 27.24 | 16.73 | 16.58 | 44.69 | 80.23 | 189.20 | 204.04 | 191.41 | 167.90 | 147.26 |
State: Current | 16.89 | (2.95) | 8.56 | 15.19 | 19.08 | 4.30 | 20.95 | 21.11 | 17.04 | 13.98 |
State: Deferred | (10.87) | 7.57 | (10.02) | (6.23) | 2.75 | 2.55 | 1.63 | 0.30 | 1.14 | 1.53 |
Federal: Current | 41.59 | (16.61) | 63.70 | 65.40 | 122.38 | 166.76 | 168.60 | 167.75 | 134.94 | 111.94 |
Federal: Deferred | (20.37) | 28.72 | (45.66) | (29.67) | (63.98) | 15.60 | 12.87 | 2.26 | 14.78 | 19.81 |
Income from Continuing Operations | 107.99 | (9.58) | 42.21 | 121.51 | 305.44 | -- | -- | -- | -- | -- |
Income from discontinued operations | 22.95 | (786.91) | (1,539.91) | 147.12 | 14.93 | -- | -- | -- | -- | -- |
Net income | 130.94 | (796.49) | (1,497.70) | 268.63 | 320.37 | 324.60 | 335.69 | 317.20 | 280.52 | 240.91 |
Net income attributable to noncontrolling interests | (0.03) | -- | -- | -- | -- | (0.32) | (0.63) | (0.08) | -- | -- |
Net Income (loss) Available to Common Shareholders | 130.96 | (796.49) | (1,497.70) | 268.63 | 320.37 | 324.91 | 336.32 | 317.28 | 280.52 | 240.91 |
Income from continuing operations: Basic | 1.27 | (0.11) | 0.50 | 1.33 | 3.31 | -- | -- | -- | -- | -- |
Income from discontinued operations:Basic | 0.27 | (9.44) | (18.44) | 1.62 | 0.16 | -- | -- | -- | -- | -- |
Net Earnings Per Share (Basic) | 1.54 | (9.55) | (17.94) | 2.95 | 3.47 | 3.52 | 3.61 | 3.22 | 2.83 | 2.47 |
Income from continuing operations: Diluted | 1.26 | (0.11) | 0.50 | 1.33 | 3.29 | -- | -- | -- | -- | -- |
Income from discontinued operations:Diluted | 0.27 | (9.44) | (18.33) | 1.60 | 0.16 | -- | -- | -- | -- | -- |
Net Earnings Per Share (Diluted) | 1.53 | (9.55) | (17.83) | 2.93 | 3.45 | 3.49 | 3.58 | 3.18 | 2.78 | 2.42 |
Weighted Average Shares Outstanding (Basic) | 84.83 | 83.40 | 83.50 | 91.10 | 92.43 | 92.42 | 93.08 | 98.59 | 99.11 | 97.39 |
Weighted Average Shares Outstanding (Diluted) | 85.83 | 83.40 | 84.01 | 91.61 | 92.96 | 93.11 | 93.96 | 99.89 | 100.97 | 99.38 |